BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3922314)

  • 1. [Thermotherapy for cancer of the urinary bladder in combination with tegafur suppository and picibanil--concentrations of tegafur in the serum and tissues in bladder carcinoma].
    Murahashi I; Mukae K; Tabata Y; Sakuma H; Kanbe K; Arai T; Kaneko K; Honda M; Maeda S; Takasaki E
    Gan To Kagaku Ryoho; 1985 May; 12(5):1152-5. PubMed ID: 3922314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thermotherapy for cancer of the urinary bladder in combination with tegafur and picibanil--with special reference to the serum bladder and bladder cancer tissue concentrations of tegafur in a perfusion fluid].
    Murahashi I; Kanbe K; Kaneko K; Honda M; Maeda S; Takahashi E
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1781-8. PubMed ID: 6433803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on the concentration of FT-207 and 5-FU in serum and tissues of bladder tumor and prostatic carcinoma].
    Kobayashi H; Sahashi M; Obata K
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2147-54. PubMed ID: 3087294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical application of tegafur suppositories for bladder tumor].
    Mishina T; Kobayashi T; Maegawa M; Nakao M; Nakagawa S; Watanabe H
    Hinyokika Kiyo; 1983 Aug; 29(8):969-77. PubMed ID: 6426274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of FT-207 rectum suppository in squamous cell carcinoma of the uterine cervix. (I) Pharmacokinetics in single administration at a dose of 1 gram].
    Okazaki H; Hasegawa T; Fujimori T; Katayama S; Sakaguchi K; Hayashi Y; Nakagiri Y; Ishii Y; Fukui H; Kohno I
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):840-7. PubMed ID: 6426395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [FT-207 and 5-FU concentrations in brain tumor tissues, plasma and CSF after administration of FT-207 suppository].
    Matsuura H; Nakazawa S
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):912-6. PubMed ID: 6426399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of FT-207 rectum suppository in squamous cell carcinoma of the uterine cervix. (II) Pharmacokinetics in continuous administration at a daily dose of 1 gram].
    Okazaki H; Hasegawa T; Endoh S; Hayashi Y; Chin N; Rin K; Nakagiri Y; Ishii Y; Fukui H; Kohno I
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):848-52. PubMed ID: 6426396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum concentration of 5-FU and tegafur (FT-207) after administration of tegafur (FT-207) suppository with the colostomy].
    Kimoto M; Nagano H; Gunge N; Murei T; Iwamoto S; Seo Y; Yamamoto Y; Sano K
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2853-8. PubMed ID: 3116942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after administration of FT-207 suppositories].
    Kumazawa H; Imai N; Shioya M; Kato K; Fukaya Y; Noguchi A
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1655-62. PubMed ID: 6433799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of serum and tissue concentrations of FT-207 and 5-FU in patients with cancer of the large intestine following preoperative application of FT-207 suppositories].
    Okuda M; Teramoto T; Yoshida H; Sato K; Ushijima Y; Uematsu Y
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1580-8. PubMed ID: 6820920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pre- and intra-operative chemotherapy using FT-207 suppositories--with special reference to lung cancer].
    Fukuda K; Komatubara S; Sato G; Teramoto S
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2212-5. PubMed ID: 6307181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combination (RaHPP) of radiotherapy, hyperthermia and chemotherapy (peplomycin and picibanil) for bladder cancer].
    Washida H; Tsugaya M; Hirao N; Hachisuka Y
    Hinyokika Kiyo; 1984 Sep; 30(9):1159-66. PubMed ID: 6084419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of chemotherapy of breast cancer (2). Clinical evaluation of the blood and tissue concentrations of FT-207 following intrarectal administration].
    Hiraide H; Mimura K; Kawano M; Hatsuse K; Kadota T; Kurokawa T; Tamaki K; Kanabe S; Mizoguchi O; Terashima H; Iwasa H
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):992-6. PubMed ID: 6408994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on the permeability of FT-207 and 5-FU in primary lung cancer].
    Aogauchi R; Tsubota N; Yamashita C; Yoshikawa K; Ishii N; Nakamura K
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):105-10. PubMed ID: 3917651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preoperative treatment of FT-207 suppository in cervical cancer-- serum and tumor tissue content of FT-207].
    Nagai S; Sawada T
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):307-11. PubMed ID: 6421248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study on concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after rectal administration of FT-207 suppositories for malignant diseases of the liver, biliary tract and pancreas].
    Takada T; Yasuda H; Uchiyama K; Hasegawa H
    Gan To Kagaku Ryoho; 1985 May; 12(5):1088-93. PubMed ID: 3922311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on 5-FU concentration in serum and bladder tumor tissue after oral administration of UFT].
    Takayama H; Konami T; Konishi T; Pak K; Tomoyoshi T
    Hinyokika Kiyo; 1986 Oct; 32(10):1449-53. PubMed ID: 3105272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum and tissue concentration of tegafur and 5-FU after administration of tegafur suppository in patients with lung cancer--correcting the influence of residual blood in the tissue].
    Ohno K; Nakahara K; Hashimoto J; Matsumura A; Mizuta T; Akashi A; Nakagawa K; Takeda S; Minami M; Kawashima Y
    Gan To Kagaku Ryoho; 1989 Nov; 16(11):3603-8. PubMed ID: 2510605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of streptococcal preparation (OK-432) local injection in patients with urinary bladder carcinoma.
    Nishio S; Izeki T; Wada S; Morikawa Y; Yasumoto R; Maekawa M
    Osaka City Med J; 1980; 26(1):47-59. PubMed ID: 7267092
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of pre-operative chemotherapy using FT-207 suppositories combined with glutathione--with special reference to histopathological antitumor effect].
    Kaga F; Kitajima M; Ikeda Y; Seki M; Yagita A; Sohma S; Fukuzumi N
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):489-95. PubMed ID: 6820899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.